MMSI
Merit Medical Systems, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +7.1% ·
share flow -15.9% ·
net new positions +6.7%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +2 | 41.26M | $2.86B | +12 | −9 |
| Q1 2026 | 119 | +2 | 38.80M | $2.68B | +10 | −9 |
| Q4 2025 | 117 | -1 | 45.00M | $3.97B | +2 | −2 |
| Q3 2025 | 21 | +1 | 28.60M | $2.38B | +1 | −1 |
| Q2 2025 | 18 | 0 | 26.61M | $2.49B | +1 | −1 |
| Q1 2025 | 15 | -1 | 7.60M | $802.99M | +1 | −2 |
| Q4 2024 | 16 | 0 | 7.36M | $712.26M | +2 | −2 |
| Q3 2024 | 15 | +1 | 4.73M | $467.42M | +1 | — |
| Q2 2024 | 14 | — | 5.63M | $483.63M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.36M | +1.3% | $134.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.36M | +1.3% | $134.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 776.17K | -0.6% | $76.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 776.17K | -0.6% | $76.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 734.70K | -6.1% | $72.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 370.74K | +49.4% | $36.64M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 353.76K | +73.0% | $34.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 347.91K | -45.2% | $34.38M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 250.00K | -16.7% | $24.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 221.69K | +3.2% | $21.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 136.03K | -37.7% | $13.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 93.31K | -2.2% | $9.22M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 42.41K | -93.3% | $4.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 14.46K | -87.7% | $1.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 14.46K | -87.7% | $1.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 13.25K | +20.0% | $1.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 13.25K | +20.0% | $1.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 13.25K | +20.0% | $1.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 9.59K | -80.1% | $947,483 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 7.97K | New | $787,972 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Gotham Asset Management | $787,972 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 398 holders, 58.87M shares, $3.96B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 7.50K sh · $678,360
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology